Evox Therapeutics publishes new research identifying ‘potent’ scaffold proteins 10-Aug-2023 By Isabel Cameron Evox Therapeutics, an exosome therapeutics company, has announced the publication of its research identifying novel exosome scaffold proteins that significantly improve drug loading into exosomes for therapeutic purposes.
National Research Council of Canada signs cannabinoid biosynthesis agreement 19-Oct-2018 By Maggie Lynch InMed Pharmaceuticals signed an agreement with the National Research Council of Canada for cannabinoid biofermentation development.